BDS Analytics’ Cannabis Retail Price Index (CPI) & Cannabis Consumer Sales Report for September 2019
Ryan Allway
November 26th, 2019
Policy, Top News
The one-of-a-kind CPI is a benchmark of retail sales pricing across cannabis products in select legalized U.S. markets. The index currently represents sales in Arizona, California, Colorado, Nevada, and Oregon, states that generated more than 50 percent of legalized U.S. sales in 2018. Underlying pricing data is the compilation of actual dispensary transactions captured by BDS Analytics’ GreenEdge™ Retail Sales Tracking Platform. The baseline of measurement represents the launch of adult-use sales in California in January of 2018. In order to standardize retail pricing data for Flower and Concentrates, all transactions are normalized to price per gram. For Ingestibles, Topicals and Vape, sales are converted to a price per unit measure.
BDS Analytics’ CPI is unique in its ability to index retail pricing across all product categories, a significant insight considering the rapid market growth largely driven by branded products in all categories.
BDS Analytics’ CPI for September 2019 stands at 102.29, representing a four percent decrease from the trailing month. Compared to September 2018, average retail prices have declined nearly two percent. Year-to-date average retail prices have declined slightly more than one percent.
The index score is positive for Pre-Rolled Joints, Ingestibles and Topicals, indicating an increase of the average retail price of these product categories relative to January 2018. Other product categories, such as Flower, Vape, and Dabbable Concentrates, have negative index scores. The average retail prices of Ingestibles, Topicals, Flower, and Vape remained stable when compared to the trailing month.
GreenEdge® Insights: In September 2019, legal cannabis sales at dispensaries across Arizona, California, Colorado, Oregon, and Nevada reached a combined $582.9 million, a nine percent decrease the trailing month and a 15 percent increase from the prior September.
Historically, September is a period of seasonal slowdowns. In fact, from August to September in 2018, dollar sales decreased by more than four percent. This year’s seasonal decline of nine percent was exacerbated by health and safety concerns related to vaping. As a result of these vape-related concerns, sales in the category declined by 21 percent from the trailing month. As vape sales ceded ground to lower-priced categories, overall prices declined while prices within individual categories remained steady.
Stay tuned for the next installment of the CPI for a recap of Cannabis sales trends with October data.
For further details about these insights and more, please contact info@bdsanalytics.com.
About BDS Analytics:
Headquartered in Boulder, Colorado, BDS Analytics provides businesses with smart, actionable and accurate cannabis market intelligence and consumer research. The company provides a holistic understanding of the cannabis and CBD markets through insights distilled from dispensary point-of-sale systems through its market-leading GreenEdge™ Platform, producing comprehensive consumer research and generating cannabis industry financial projections and analyses led by BDS Analytics’ industry-leading team of thought leaders and analysts. To learn more about our CPI or BDS Analytics’ products and services, please contact info@bdsanalytics.com.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
TransCanna™ specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products.
Aleafia, a vertically integrated, national cannabis company, operates major medical clinic, cannabis cultivation and R&D facilities.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
